Literature DB >> 1367008

Oligonucleoside methylphosphonates as antisense reagents.

P S Miller1.   

Abstract

Oligonucleoside methylphosphonates contain nonionic internucleotide bonds that resist degradation by cellular nucleases and allow the oligomers to be taken up intact by mammalian cells in culture. Antisense methylphosphonate oligomers targeted against cellular or viral mRNA initiation codon or coding regions or against precursor mRNA splice sites effectively and specifically inhibit mRNA expression in cells. The efficacy of antisense methylphosphonate oligomers can be enhanced by derivatization with functional groups that allow the oligomer to covalently cross-link with its targeted mRNA. These oligonucleotide analogs will be useful tools for studying and controlling gene expression and are also promising candidates for development as therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367008     DOI: 10.1038/nbt0491-358

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  10 in total

1.  Targeting a KH-domain protein with RNA decoys.

Authors:  Aleksandr V Makeyev; Dawn L Eastmond; Stephen A Liebhaber
Journal:  RNA       Date:  2002-09       Impact factor: 4.942

2.  Oligonucleotide N3'-->P5' phosphoramidates.

Authors:  S M Gryaznov; D H Lloyd; J K Chen; R G Schultz; L A DeDionisio; L Ratmeyer; W D Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

3.  Site-specific and photo-induced alkylation of DNA by a dimethylanthraquinone-oligodeoxynucleotide conjugate.

Authors:  H Kang; S E Rokita
Journal:  Nucleic Acids Res       Date:  1996-10-15       Impact factor: 16.971

4.  Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers.

Authors:  A Bielinska; J F Kukowska-Latallo; J Johnson; D A Tomalia; J R Baker
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

Review 5.  In vivo imaging with oligonucleotides for diagnosis and drug development.

Authors:  B Tavitian
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

6.  Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modifications.

Authors:  R A McKay; L L Cummins; M J Graham; E A Lesnik; S R Owens; M Winniman; N M Dean
Journal:  Nucleic Acids Res       Date:  1996-02-01       Impact factor: 16.971

7.  Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition.

Authors:  L Xodo; M Alunni-Fabbroni; G Manzini; F Quadrifoglio
Journal:  Nucleic Acids Res       Date:  1994-08-25       Impact factor: 16.971

8.  Deprotection of methylphosphonate oligonucleotides using a novel one-pot procedure.

Authors:  R I Hogrefe; M M Vaghefi; M A Reynolds; K M Young; L J Arnold
Journal:  Nucleic Acids Res       Date:  1993-05-11       Impact factor: 16.971

9.  A Drosera-bioinspired hydrogel for catching and killing cancer cells.

Authors:  Shihui Li; Niancao Chen; Erin R Gaddes; Xiaolong Zhang; Cheng Dong; Yong Wang
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

Review 10.  Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides.

Authors:  Steven Ochoa; Valeria T Milam
Journal:  Molecules       Date:  2020-10-13       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.